Policymaker, Please Consider Your Needs Carefully: Does Outcomes Research in Relapsed or Refractory Multiple Myeloma Reduce Policymaker Uncertainty Regarding Value for Money of Bortezomib?

M.G. Franken, J.G. Gaultney, H.M. Blommestein, P.C. Huijgens, P. Sonneveld, W.K. Redekop, C.A. Uyl-de Groot

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)245-253
JournalValue in Health
Issue number2
Publication statusPublished - 2014

Cite this